Viewing Study NCT07175051


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-25 @ 9:49 PM
Study NCT ID: NCT07175051
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2025-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Sponsor: University of Illinois at Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module